Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Fawley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 28, 2006
Measurement of toxin production by Clostridium difficileJane Freeman, Warren Fawley, Simon Baines, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoeaMark H Wilcox, Jane Freeman, Warren Fawley, et al.
Sexually Transmitted Diseases|June 10, 2021
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae InfectionLing Yuan Kong, Janet D Wilson, Ines B Moura, et al.
Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in <i>Clostridioides difficile</i> varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.
Plos One|June 1, 2011
Clinical Clostridium difficile: clonality and pathogenicity locus diversityKate E Dingle, David Griffiths, Xavier Didelot, et al.
Journal of Clinical Microbiology|January 1, 2010
Multilocus sequence typing of Clostridium difficileDavid Griffiths, Warren Fawley, Melina Kachrimanidou, et al.
Plos One|August 17, 2017
Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strainsNicole Stoesser, David W Eyre, T Phuong Quan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 28, 2006
Measurement of toxin production by Clostridium difficileJane Freeman, Warren Fawley, Simon Baines, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoeaMark H Wilcox, Jane Freeman, Warren Fawley, et al.
Sexually Transmitted Diseases|June 10, 2021
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae InfectionLing Yuan Kong, Janet D Wilson, Ines B Moura, et al.
Jac-Antimicrobial Resistance|July 24, 2024
Antimicrobial susceptibility in <i>Clostridioides difficile</i> varies according to European region and isolate sourceJane Freeman, Virginie Viprey, Duncan Ewin, et al.
Plos One|June 1, 2011
Clinical Clostridium difficile: clonality and pathogenicity locus diversityKate E Dingle, David Griffiths, Xavier Didelot, et al.
Journal of Clinical Microbiology|January 1, 2010
Multilocus sequence typing of Clostridium difficileDavid Griffiths, Warren Fawley, Melina Kachrimanidou, et al.
Plos One|August 17, 2017
Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strainsNicole Stoesser, David W Eyre, T Phuong Quan, et al.
Pageof 1